REQUEST A DEMO
Total
USD $0.00
Search more companies

UAB Johnson & Johnson (Lithuania)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: UAB Johnson & Johnson Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

UAB Johnson & Johnson is based in Lithuania. The head office is in Vilnius. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was established on August 14, 2002. 42 (2025) employees currently work for UAB Johnson & Johnson. In its most recent financial highlights, the company reported a net sales revenue increase of 10.96% in 2024. In, 2024, the company’s net profit margin decreased by 0.29%.

Headquarters
Konstitucijos pr. 21C
Vilnius; Vilnius county; Postal Code: LT-08105

Contact Details: Purchase the UAB Johnson & Johnson report to view the information.

Basic Information
Total Employees:
Purchase the UAB Johnson & Johnson report to view the information.
Registered Capital:
Purchase the UAB Johnson & Johnson report to view the information.
Financial Auditors:
Purchase the UAB Johnson & Johnson report to view the information.
Incorporation Date:
August 14, 2002
Key Executives
Purchase this report to view the information.
Member of the Management Board
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after UAB Johnson & Johnson report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
10.96%
Total operating revenue
10.96%
Net Profit (Loss) for the Period
3.57%
Total equity
-67.64%
Net Profit Margin
-0.29%
Return on Equity (ROE)
25.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?